Thomas W. Dubensky

Insider Reports History

Location
Berkeley, CA
Signature
/s/ Stephen Brady, Attorney-in-Fact for Thomas W. Dubensky
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas W. Dubensky:

Company Role Class Num Shares Value Price $ Report Date Ownership
Tempest Therapeutics, Inc. President, Director Common Stock 113,343 $267,489 $2.36 07 Jan 2022 Direct
Tempest Therapeutics, Inc. President, Director Employee Stock Option (right to buy) 102,700 03 Jan 2023 Direct
HTG MOLECULAR DIAGNOSTICS, INC Director Stock Option (right to buy) 8,000 18 Aug 2022 Direct

Insider Reports Filed by Thomas W. Dubensky

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TPST Tempest Therapeutics, Inc. 03 Jan 2023 1 $0 4 President, Director 05 Jan 2023, 19:01
HTGMQ HTG MOLECULAR DIAGNOSTICS, INC 18 Aug 2022 1 $0 4 Director 22 Aug 2022, 17:27
HTGMQ HTG MOLECULAR DIAGNOSTICS, INC 18 Aug 2022 0 $0 3 Director 19 Aug 2022, 16:30
TPST Tempest Therapeutics, Inc. 21 Jun 2022 1 $0 4 President, Director 22 Jun 2022, 16:31
TPST Tempest Therapeutics, Inc. 07 Jan 2022 1 $9,560 4 President, Director 11 Jan 2022, 17:36
TPST Tempest Therapeutics, Inc. 04 Jan 2022 1 $0 4 President, Director 06 Jan 2022, 18:22
TPST Millendo Therapeutics, Inc. 25 Jun 2021 5 $0 4 President, Director 29 Jun 2021, 21:55
TPST Millendo Therapeutics, Inc. 25 Jun 2021 0 $0 3 President, Director 29 Jun 2021, 21:21